Last update:

Alzheimer's disease & dementia news

Alzheimer's disease & dementia

SARS-CoV-2 can cause buildup of Alzheimer's-related peptides in retina

A new Yale study has found a promising target for treating the brain fog that can follow COVID-19 and offers new insight into a hypothesis about the origin of Alzheimer's disease.

Psychology & Psychiatry

Demystifying the link between major depression and Alzheimer's disease

More than 7 million people in the United States live with Alzheimer's disease and related dementia (ADRD). Some risk factors for ADRD, like genetics, can't be controlled, but others can be treated. One of the most prevalent ...

Alzheimer's disease & dementia

People diagnosed with dementia are living longer, global study shows

A person diagnosed with dementia has improved survival outcomes in recent years amid significant progress in dementia diagnosis and care, according to a recent multinational study led by a University of Waterloo researcher.

Psychology & Psychiatry

New study maps four key pathways to Alzheimer's disease

UCLA Health researchers have identified four distinct pathways that lead to Alzheimer's disease by analyzing electronic health records, offering new insights into how the condition develops over time rather than from isolated ...

Genetics

Master copper regulator discovery may offer Alzheimer's clues

New therapeutic opportunities often emerge from research on simple organisms. For instance, the 2020 Nobel Prize in Chemistry awarded to Emmanuelle Charpentier, Ph.D., and Jennifer Doudna, Ph.D., for their CRISPR-based DNA ...

Alzheimer's disease & dementia

Boosting brain protein levels may slow decline from Alzheimer's

A study published in the journal Brain shows that increases in protein levels with new Alzheimer's drugs can explain the slowing of cognitive impairment at least as well as the reduction in amyloid plaques.